AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TIGECYCLINE

15 registrations across 4 African markets— 8 active

Markets with TIGECYCLINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
TIGECYCLINE ADCO🇿🇦South AfricaAdcock Ingram LimitedactiveMay 2028
CYTAGIL IV🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveApr 2028
TIGECYCLINE 50 mg PFIZER🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveFeb 2028
TYGEPOL
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweWMT PHARMACEUTICALSactiveDec 2027
TACYL🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedMar 2026
GATICIL IV IV🇿🇦South AfricaPharma Dynamics (Pty) LtdsuspendedJun 2023
TAGIX
Poudre pour solution pour perfusion / 50 mg
🇹🇳TunisiaHIKMA PharmaceuticalsexpiredApr 2022
TEGADIS
Poudre pour solution pour perfusion / 50 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredMar 2022
TEGADIS
Poudre pour solution pour perfusion / 50 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredMar 2022
TYGACIL
Pdre p.prep.injectable / 50 mg
🇹🇳TunisiaPFIZER Europe MA EEIGexpiredJan 2022
TYGACIL
Pdre p.prep.injectable / 50 mg
🇹🇳TunisiaPFIZER Limited UKexpiredJun 2015
RUBICIL🇿🇦South AfricaRuby Pharmaceuticals (Pty) LtdactiveJan 1900
TIGEBAX🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveJan 1900
TYGACIL🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
TYLIN
Lyophilized Powder for Injection
🇹🇿TanzaniaGufic Biosciences Limitedactive

TIGECYCLINE in Africa — Regulatory Overview

TIGECYCLINE is registered across 4 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 8 (53%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.